Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Revvity, Inc.
IPO Date: January 1, 1984
Sector: Healthcare
Industry: Diagnostics and Research
Market Cap: $10.87B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.32 | 1.21%
Avg Daily Range (30 D): $1.52 | 1.61%
Avg Daily Range (90 D): $1.76 | 1.70%
Institutional Daily Volume
Avg Daily Volume: .72M
Avg Daily Volume (30 D): 1.16M
Avg Daily Volume (90 D): .98M
Trade Size
Avg Trade Size (Sh.): 45
Avg Trade Size (Sh.) (30 D): 50
Avg Trade Size (Sh.) (90 D): 47
Institutional Trades
Total Inst.Trades: 1,565
Avg Inst. Trade: $6.93M
Avg Inst. Trade (30 D): $6.81M
Avg Inst. Trade (90 D): $7.38M
Avg Inst. Trade Volume: .06M
Avg Inst. Trades (Per Day): 3
Market Closing Trades
Avg Closing Trade: $14.85M
Avg Closing Trade (30 D): $18.32M
Avg Closing Trade (90 D): $17.21M
Avg Closing Volume: 136.03K
       
News
May 14, 2025 @ 5:00 PM
Global Preeclampsia Diagnostics Market to Exhibit ...
Source: Delveinsight
Apr 22, 2025 @ 6:56 PM
High Content Screening and Imaging Market Set for ...
Source: Bcc Research
Jan 15, 2025 @ 12:00 PM
Neurogenomics Market Forecast and Trends Analysis ...
Source: Researchandmarkets.Com
Oct 24, 2024 @ 12:15 PM
Infectious Disease Diagnostics Market to Reach USD...
Source: Globe Newswire
Oct 21, 2024 @ 2:54 PM
CRISPR-based Gene Editing Market Report 2024-2030,...
Source: Researchandmarkets.Com
Financials
  TTM FY 2024 Q3 2024
Basic EPS $.35 $2.21 $.77
Diluted EPS $.35 $2.2 $.77
Revenue $ 664.76M $ 2.76B $ 684.05M
Gross Profit $ 375.55M $ $ 384.82M
Net Income / Loss $ 42.24M $ 270.39M $ 94.37M
Operating Income / Loss $ 72.23M $ 346.74M $ 98.15M
Cost of Revenue $ 289.22M $ $ 299.23M
Net Cash Flow $ -25.77M $ 250.08M $ -18.62M
PE Ratio 254.27    
Splits
Jun 04, 2001:   2:1